InspireMD Q1 2024 GAAP EPS $(0.21) Misses $(0.15) Estimate, Sales $1.511B Beat $1.384M Estimate
InspireMD Q1 2024 GAAP EPS $(0.21) Misses $(0.15) Estimate, Sales $1.511B Beat $1.384M Estimate
InspireMD 2024年第一季度公認會計准則每股收益美元（0.21）未達到預期（0.15）美元，銷售額爲15.11億美元，超過13.84萬美元的預期
InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.15) by 40 percent. This is a 60.38 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $1.511 billion which beat the analyst consensus estimate of $1.384 million by 109.08K percent. This is a 121.85K percent increase over sales of $1.239 million the same period last year.
InspireMD（納斯達克股票代碼：NSPR）公佈的季度虧損爲每股0.21美元，比分析師普遍預期的0.15美元（0.15美元）低40％。這比去年同期每股虧損0.53美元（0.53）增長了60.38％。該公司公佈的季度銷售額爲15.11億美元，比分析師普遍預期的13.84億美元高出10.98萬個百分點。這比去年同期的123.9萬美元銷售額增長了12.185萬個百分點。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。